跳到正文
原文
Nature 健康护理主题·· 2026-10-12AI 评分28

喷雾型益生菌制剂预防细菌性阴道炎的探索性单臂试点临床研究

Exploratory pilot study of a spray-type probiotic delivery system for vaginal health in women at risk for bacterial vaginosis

AI 导读

一项在Ewha Womans University Hospital开展的单臂探索性试点研究评估了新型喷雾型益生菌粉(BalanceTalk Probiotic Feminine Hygiene Powder)对细菌性阴道炎(BV)的疗效。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Bacterial vaginosis (BV) is a common gynecological condition affecting women of reproductive age, characterized by disruption of vaginal microbiota. Current probiotic interventions, including oral supplements and vaginal suppositories, face limitations in vaginal colonization and user compliance. This study evaluated the preliminary clinical, microbiological, and safety outcomes of a novel spray-type probiotic powder (BalanceTalk Probiotic Feminine Hygiene Powder) containing multiple Lactobacillus strains for BV prevention and treatment. This single-arm exploratory clinical study was conducted at Ewha Womans University Hospital from December 2023 to June 2025. Premenopausal women aged 19–55 years were enrolled and instructed to apply the spray-type probiotic powder (containing L. plantarum, L. rhamnosus, L. paracasei, and L. crispatus) to underwear or panty liners in contact with the vulvovaginal area once daily for 4 weeks. Primary outcomes included vaginal symptom improvement and Nugent score changes. Secondary outcomes assessed vaginal microbiome composition using 16 S rRNA gene sequencing. Statistical analyses included Wilcoxon signed-rank test, McNemar’s test, and mixed-effects logistic regression. Of 60 enrolled participants, 45 completed the study (75% completion rate). Overall improvement in vaginal symptoms approached statistical significance (p = 0.051), particularly in the high-risk group (Nugent score ≥ 4; p = 0.020). In the high-risk group (n = 16), mean Nugent scores decreased significantly from 6.13 to 4.63 (p < 0.001), with 8 of 16 participants (50.0%) showing a reduction in Nugent score. Lactobacillus abundance was significantly associated with lower Nugent score (OR = 0.077, 95% CI: 0.009–0.634). Alpha diversity indices correlated significantly with Nugent score (p < 0.05). Beta diversity and overall Lactobacillus abundance showed no significant changes. Three mild adverse events were reported with no serious safety concerns observed. The spray-type probiotic was associated with improvement in vaginal symptoms and reduced Nugent scores, particularly among women with baseline Nugent scores ≥4, with no serious safety concerns observed. The observed negative correlation between Lactobacillus abundance and Nugent score is consistent with the known role of Lactobacillus in maintaining vaginal health, although a causal effect of the intervention cannot be established from this single-arm study. Larger randomized controlled trials are warranted to confirm these findings and establish clinical utility.

Abbreviations

AE:

Adverse event

ASV:

Amplicon sequence variant

BV:

Bacterial vaginosis

CI:

Confidence interval

DNA:

Deoxyribonucleic acid

ICH-GCP:

International Council for Harmonisation–Good Clinical Practice

IRB:

Institutional Review Board

MTL:

Multi-task learning

OR:

Odds ratio

PCoA:

Principal Coordinates Analysis

PERMANOVA:

Permutational Multivariate Analysis of Variance

QIIME2:

Quantitative Insights Into Microbial Ecology 2

rRNA:

Ribosomal ribonucleic acid

SAE:

Serious adverse event

SD:

Standard deviation

SRA:

Sequence Read Archive

Acknowledgements

The authors thank all study participants for their time and commitment to this research. The authors acknowledge the use of ChatGPT (OpenAI, USA) for assistance with English language editing. The authors take full responsibility for the content of the manuscript.

Funding

This study was funded by PH4 Co., Ltd. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the Ewha Womans University Research Grant of 2024. This research was supported by the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: RS-2023-00262969).

Author information

Authors and Affiliations

  1. ¹Department of Obstetrics and Gynecology, Ewha Womans University Medical Center, Seoul, Republic of Korea

    Sunwha Park, Young-Ah You, Young Min Hur, Gain Lee, Dahye Son, Hae Ni Lee & Young Ju Kim

  2. Graduate School of Transdisciplinary Health Sciences, Yonsei University, Seoul, Republic of Korea

    Juan Kim & Min Jin Ha

  3. PH4 co.ltd., Seoul, Republic of Korea

    Yongwun Jung

Authors

  1. Sunwha Park
  2. Juan Kim
  3. Young-Ah You
  4. Young Min Hur
  5. Yongwun Jung
  6. Gain Lee
  7. Dahye Son
  8. Hae Ni Lee
  9. Min Jin Ha
  10. Young Ju Kim

Corresponding authors

Correspondence to Min Jin Ha or Young Ju Kim.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

This study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. The study protocol was reviewed and approved by the Institutional Review Board (IRB) of Ewha Womans University Hospital (IRB approval number: 2023-12-037). All participants provided written informed consent prior to enrollment and any study procedures.

Consent for publication

This manuscript does not contain any individual person’s data in any form.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, S., Kim, J., You, YA. et al. Exploratory pilot study of a spray-type probiotic delivery system for vaginal health in women at risk for bacterial vaginosis. Sci Rep (2026). https://doi.org/10.1038/s41598-026-74965-8

Download citation

  • Received: 28 May 2026

  • Accepted: 05 October 2026

  • Published: 12 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-74965-8

Keywords

来源:Nature 健康护理主题 · nature.com